subject: In Recent Years, Bulk Drugs And Intermediates Ciprofloxacin Market Analysis [print this page] China more than 90% of ciprofloxacin (API) and intermediates manufacturing companies are concentrated in the Zhejiang region, according to surveys, over Zhejiang Jiashan, Zhejiang Medicine Co., Ltd. is the largest of ciprofloxacin (API) and The key intermediate manufacturer. Ciprofloxacin has two existing production process. A process which requires active substances used as intermediates of methyl amine compounds or cyclopropane carboxylic acid as starting materials to produce ciprofloxacin; also need to use a chelating Production cyproterone acetate as the starting raw materials to produce boric acid ciprofloxacin. Prudential up drug production in methyl amine compounds, cyclopropane carboxylic acid, boric acid ester Cyclopropyl three products that use these two processes for the production API Enterprise as a key intermediate to ciprofloxacin, which cyclopropane borate only the company's domestic production. According to different production processes to the industry average yield of conversion products, the production needs of 1.1 tons per ton of ciprofloxacin hydrochloride for methyl amine compounds or 0.9 tons of cyclopropane carboxylic acid, or 0.8 tons of cyclopropane acid ester, if the intermediate body converted into the amount of ciprofloxacin, the company's sales in 2007 and 2008, respectively 350 tons and 384 tons, or about 20% of domestic sales of ciprofloxacin.
In Recent Years, Bulk Drugs And Intermediates Ciprofloxacin Market Analysis
